Synthetic Biologics, Inc. (SYN)
EBITDA Margin
0.00%
Quarterly · Period ending:
SYN EBITDA Margin
Latest reported0.00%period ending
Latest reported0.00%period ending
SYN Quarterly EBITDA Margin (0.00% → 0.00%)
Quarterly ebitda margin
High-resolution chart · PNG
SYN ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 320.5826% | |
| -365.7877% | |
| -465.5883% | |
| -650.7421% | |
| -125.1645% | |
| -221.1881% | |
| 48.7214% | |
| -1,657.0496% | |
| -1,911.9952% | |
| -1,060.6166% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 11,939.0164% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -20,523.4947% | |
| 153,623.19% | |
| 0% | |
| -1,214.8867% | |
| 0% | |
| 0% | |
| -32,161.72% | |
| 0% | |
| 0% | |
| 0% | |
| -333.612% | |
| -890.324% | |
| -757.148% | |
| -2,930.751% | |
| -1,137.4812% | |
| -1,228.1109% | |
| -4,432.9005% | |
| -1,400% | |
| -1,300% |